SWK (NASDAQ:SWKH - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.18 by $0.20, Zacks reports. The business had revenue of $10.05 million for the quarter. SWK had a return on equity of 8.43% and a net margin of 39.00%.
SWK Stock Performance
Shares of NASDAQ:SWKH traded up $0.04 during trading on Wednesday, reaching $14.08. 517 shares of the stock were exchanged, compared to its average volume of 15,363. SWK has a 12 month low of $13.17 and a 12 month high of $20.49. The firm has a market cap of $172.76 million, a PE ratio of 9.92 and a beta of 0.16. The stock has a 50-day moving average price of $14.85 and a 200-day moving average price of $15.57. The company has a current ratio of 3.17, a quick ratio of 11.30 and a debt-to-equity ratio of 0.13.
Institutional Investors Weigh In On SWK
Institutional investors have recently made changes to their positions in the stock. Bank of America Corp DE boosted its stake in shares of SWK by 41.8% in the second quarter. Bank of America Corp DE now owns 5,595 shares of the company's stock valued at $82,000 after buying an additional 1,649 shares during the period. Empowered Funds LLC boosted its stake in shares of SWK by 3.7% in the first quarter. Empowered Funds LLC now owns 53,809 shares of the company's stock valued at $936,000 after buying an additional 1,929 shares during the period. Raymond James Financial Inc. boosted its stake in shares of SWK by 297.5% in the second quarter. Raymond James Financial Inc. now owns 74,657 shares of the company's stock valued at $1,100,000 after buying an additional 55,874 shares during the period. Finally, Bridgeway Capital Management LLC boosted its stake in shares of SWK by 2.9% in the second quarter. Bridgeway Capital Management LLC now owns 114,277 shares of the company's stock valued at $1,684,000 after buying an additional 3,263 shares during the period. 99.27% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several analysts recently commented on SWKH shares. Maxim Group dropped their price objective on SWK from $21.00 to $18.00 and set a "buy" rating on the stock in a research note on Monday, May 19th. Wall Street Zen cut SWK from a "buy" rating to a "hold" rating in a report on Thursday, May 22nd. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $18.00.
View Our Latest Stock Report on SWKH
SWK Company Profile
(
Get Free Report)
SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.
See Also

Before you consider SWK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SWK wasn't on the list.
While SWK currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.